Signaling lipids direct many steps in the migration and activation of cells of the immune system. For example, eicosanoids are among the first signals that direct cells of the innate immune system to a site of injury 1 . The efficiency of T cell entry into lymph nodes is increased by lysophosphatidic acid, which regulates the motility of both T cells and endothelial cells 2, 3 . Within lymphoid organs, thromboxane A2 modulates the interactions of T cells with dendritic cells, and 7α-25 hydroxycholesterol recruits activated B cells to the rim of the follicles and positions dendritic cells in splenic bridging channels [4] [5] [6] . The exit of lymphocytes from lymphoid organs into the circulation is guided by sphingosine 1-phosphate (S1P) 7 . However, despite the clear importance of signaling lipids, many questions remain about their function, in part because few tools to map their location in vivo are available.
Signaling lipids direct many steps in the migration and activation of cells of the immune system. For example, eicosanoids are among the first signals that direct cells of the innate immune system to a site of injury 1 . The efficiency of T cell entry into lymph nodes is increased by lysophosphatidic acid, which regulates the motility of both T cells and endothelial cells 2, 3 . Within lymphoid organs, thromboxane A2 modulates the interactions of T cells with dendritic cells, and 7α-25 hydroxycholesterol recruits activated B cells to the rim of the follicles and positions dendritic cells in splenic bridging channels [4] [5] [6] . The exit of lymphocytes from lymphoid organs into the circulation is guided by sphingosine 1-phosphate (S1P) 7 . However, despite the clear importance of signaling lipids, many questions remain about their function, in part because few tools to map their location in vivo are available.
A series of studies has shed light on the distribution of protein chemokines by targeting of genes encoding fluorescent reporters into the chemokine-encoding locus [8] [9] [10] . However, lipids are not encoded genetically, and the abundance of signaling-available lipids is determined by the balance of the activity of synthetic enzymes, degrading enzymes and transporters. For example, S1P is made intracellularly by two sphingosine kinases, is degraded intracellularly by two phosphatases and S1P lyase, is exported out of the cell by the transporter SPNS2 and at least one additional unidentified transporter, and is degraded extracellularly by three phosphatases 11 . Because of the complexity of the pathway, expression of any one of these enzymes is not predictive. Mass spectrometry has been widely used to quantify lipids, but measurements in tissues cannot distinguish extracellular lipid from intracellular lipid and lipid in the inner leaflet of the plasma membrane. Intracellular lipid can substantially confound interpretation, because many lipids act both extracellularly as ligands for cell-surface receptors and intracellularly as metabolic intermediates and protein co-factors. For example, extracellular S1P guides cell migration by signaling through G protein-coupled receptors.
At the same time, intracellular phosphorylation of sphingosine to S1P and subsequent cleavage by S1P lyase at the endoplasmic reticulum membrane are the final two steps in degradation of sphingolipids, and S1P might bind to and alter the function of diverse cytoplasmic and nuclear proteins 12 ; in many cases, the concentration of total tissue S1P has been reported to be very high 7 . Although signaling molecules have in some settings been measured in interstitial fluid extracted by a probe, the synthesis of many signaling lipids is induced in response to inflammatory stimuli, which makes the insertion of a needle problematic. For example, the mitogen-activated kinase Erk1/2 phosphorylates the sphingosine kinase SPHK1 and increases its catalytic activity 13 . Moreover, it is not clear how much extracellular lipid is sequestered by proteins or is available to bind receptors.
A combination of techniques has given insight into the distribution of S1P, but many questions about S1P's location and function remain unanswered. There is good evidence that the concentration of S1P is high in lymph and blood compared with its concentration in the interstitial fluid of lymphoid organs, and this differential guides lymphocytes out of lymphoid organs into circulation 7 . Two types of experiment support the proposal of the existence of this gradient. First, mass spectrometry measurements of S1P in blood plasma and lymph fluid report concentrations in the range of 100 nM-1 µM, well above the 0.5 nM median inhibitory concentration of S1P receptor 1 (S1PR1) 7, 14 . Second, the amount of S1PR1 is low on the surface of naive lymphocytes in blood and lymph, while it is abundant on the surface of the same cells in lymphoid organs. S1PR1, like many G protein-coupled receptors, is internalized in response to binding ligand 15, 16 . In the absence of other transcriptional, translational or post-translational changes in receptor expression, differences in the surface expression of S1PR1 reflect differences in exposure to S1P. This inference has been confirmed in many settings for naive lymphocytes trafficking among lymphoid organs in homeostasis 7 .
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However, the techniques noted above have substantial limitations. First, inflammation induces an array of transcriptional and posttranslational modifications to S1PR1, so in this setting, surface expression of S1PR1 no longer simply reflects exposure to S1P 7 . Hence, there is little understanding of how the concentration of extracellular, signalingavailable S1P changes over the course of an immune response in lymphoid or non-lymphoid tissues, although S1P has been hypothesized to increase in concentration in inflamed tissues and to alter both the trafficking and the cytokine responses of cells of the immune system 17 . Second, such techniques offer little insight into the shape of S1P gradients within tissues. S1P has been suggested to orchestrate many cell movements simultaneously, although it can be difficult to reconcile the intricate 'dance' with the crude understanding of S1P's distribution.
The spleen serves as a good example of the problem of measuring S1P in tissues 18, 19 . The spleen can be considered a blood filter. Splenic arterioles terminate in the marginal sinus, which is highly fenestrated. Blood travels out into the marginal zone, where marginal zone B cells (MZ B cells) and macrophages capture antigen for presentation to lymphocytes in the white pulp. Blood flow continues into the red pulp, where red blood cells are tested for abnormalities before they return to circulation in the venous sinuses. The concentration of S1P is thought to be low in the white pulp, on the basis of the high expression of S1PR1 on the surface of naive lymphocytes in the spleen. The marginal zone and red pulp are thought to have a high concentration of S1P, on the basis of the high concentration of S1P in the blood and the abundance of red blood cells, which are the main producers of blood S1P 20, 21 . However, this simple dichotomy cannot explain many of the migratory steps that S1P is thought to direct within the spleen. S1P receptors have been linked to confining B cells and T cells in germinal centers in the B cell follicles within the white pulp, shuttling MZ B cells from the white pulp to the marginal zone, directing the exit of lymphocytes from the white pulp to circulation, partitioning dendritic cells between the red pulp bridging channels and marginal zone, and enabling the exit of plasma cells and hematopoietic stem cells from the red pulp into venous sinuses 20, [22] [23] [24] [25] [26] . Here we report a tool for mapping signaling-available S1P in tissues using a strategy that might be widely applicable to GPCR ligands. We used this tool to map S1P in the spleen and define how its distribution is regulated.
RESULTS
Generation of an S1P reporter mouse
We set out to generate a mouse expressing a reporter that would enable us to map signaling-available S1P (S1P that is both extracellular and free to bind receptors rather than sequestered) in tissues (Fig. 1a,b) . The core of this reporter was S1PR1 itself fused to enhanced green fluorescent protein (eGFP). In the absence of S1P, S1PR1-eGFP should sit on the cell surface; in the presence of S1P, S1PR1-eGFP should be internalized in endosomes. As a control, the reporter we designed also encoded a mutant version of S1PR1 with a single amino acid change (substitution of alanine for the arginine at position 120) in the S1P-binding pocket to prevent the receptor from binding S1P 27 . This mutant S1PR1, which we called 'non-binding (NB) S1PR1' (S1PR1 NB ), was fused to TagRFP (tRFP), a monomeric red fluorescent protein. S1PR1 NB should sit on the cell surface regardless of the presence of S1P and served three purposes: to mark the plasma membrane, to enable measurement of the ratio of S1PR1-eGFP to S1PR1 NB -tRFP on the plasma membrane, and to 'flag' situations with ligand-independent internalization of S1PR1. The two receptors were separated by a P2A ribosomal skip sequence so that they were subject to the same translational control. The reporter was knocked into the ubiquitously expressed Rosa26 locus, and transcription was driven by the synthetic CAG (cytomegalovirus-β-actin-β-globin) promoter to drive widespread expression 28 . The reporter was preceded by a loxP-flanked transcriptional stop to avoid potential developmental artifacts caused by overexpression of S1PR1.
Before making a mouse, we tested the utility of our strategy in cell culture. We retrovirally transduced a B cell lymphoma line with the reporter. As expected, in the absence of S1P, both S1PR1-eGFP and S1PR1 NB -tRFP sat on the cell surface (Fig. 1c) . In the presence of S1P at a concentration comparable to that in blood, S1PR1-eGFP was internalized, while S1PR1 NB -tRFP remained on the surface. Upon treatment of the cells with the phorbol ester PMA, which activates protein kinase C and in turn causes ligand-independent internalization of many G protein-coupled receptors 29 , both S1PR1-eGFP and S1PR1 NB -tRFP were internalized. The only situation we encountered in which S1PR1 NB -tRFP did not 'flag' ligand-independent trafficking of S1PR1 was internalization mediated by the activation marker CD69 (ref. 30) (data not shown).
We then generated a mouse expressing the reporter. In our initial experiments, we used Cre recombinase driven by the interferon-inducible Mx1 promoter (Mx1-Cre) to induce transcription of the reporter 31 . Treatment of mouse pups with the synthetic RNA duplex poly(I:C) at 3-5 d after birth resulted in widespread reporter expression in cells, including subsets of macrophages, endothelial cells, epithelial cells and stromal cells (Fig. 1d and Supplementary Fig. 1a ). We were unable to detect the reporter in lymphocytes. As expected, deep in the white pulp of the spleen, cells displayed both S1PR1-eGFP and S1PR1 NB -tRFP on the surface. In the blood-rich marginal zone of the spleen, cells displayed S1PR1 NB -tRFP on the surface, while much S1PR1-eGFP was internalized. In the spleen in homeostasis, we did not detect any instances in which S1PR1 NB -tRFP failed to localize at the cell surface. Notably, neither S1PR1-eGFP nor S1PR1 NB -tRFP trafficked to the luminal side of epithelial cells lining large intestine crypts; although on the basis of the results for S1PR1-eGFP alone, we might have concluded that the abundance of S1P was substantial in the intestinal mucus, S1PR1 NB -tRFP prevented us from making that erroneous conclusion, and this example confirmed the need for the S1PR1 NB -tRFP control in vivo.
We also made a second mouse in which a fusion of the plasma membrane protein human CD2 and tRFP (hCD2-tRFP) replaced S1PR1 NB -tRFP as an internal control. In this reporter, hCD2 lacks 100 amino acids in the cytoplasmic tail required for signaling 32 . The hCD2-tRFP reporter was more robustly expressed by many cell types in the spleen than was the S1PR1 NB -tRFP reporter (data not shown). Therefore, in cases in which the two reporters were qualitatively equivalent, we used the hCD2 reporter for analysis. Cells in the spleen of these mice fell into three categories: cells with red membranes, often with green endosomes (detection of endosomes depends on the plane of imaging), such as CD169 + macrophages in the marginal zone that were sensing abundant S1P (Fig. 1e) ; cells with yellow membranes, which were sensing less S1P; and cells with green membranes (these cells also had hCD2-tRFP on the membrane but appeared green due to the microscope and software settings, chosen to reveal the greatest range of reporting), such as CD169 + macrophages deep in the white pulp that were sensing very little S1P ( Fig. 1e and Supplementary  Fig. 1b ). These observations suggested that the S1P reporter would be an informative tool for measuring the distribution of S1P.
Analysis of S1P's distribution in the red pulp The spleen was a potentially informative organ for the first application of the S1P reporter. While some aspects of S1P's distribution in the spleen are well established and allowed testing of the fidelity of the reporter, many questions remained unanswered. As described above, the white pulp is thought to have a low concentration of S1P, while the blood-rich marginal zone and red pulp are thought to have high concentrations of S1P (Supplementary Fig. 1c) . In tissue sections, the three regions can be npg delineated by staining with antibody to the integrin ligand MAdCAM1 and antibody to the macrophage marker F4/80. The boundary between the marginal zone and the white pulp is marked by MAdCAM1, which has high expression by the marginal sinus (and less abundant expression by some stromal cells in the B follicle). The red pulp is marked by F4/80, which has high expression by red pulp macrophages.
While our S1P reporter mouse confirmed the presence of S1P in the marginal zone, it also revealed, unexpectedly, that many regions of the red pulp had little signaling-available S1P ( Fig. 2a and Supplementary  Figs. 2 and 3a) . S1PR1-eGFP was partially internalized by CD169 + macrophages in the marginal zone, while it was largely on the surface of F4/80 + macrophages in the red pulp, particularly in areas of small densely clustered macrophages ( Fig. 2a and Supplementary Figs. 2  and 3a) . This observation was reflected in a lower ratio of eGFP to tRFP on the surface of macrophages in the marginal zone than on those in the red pulp ( Fig. 2b and Supplementary Fig. 3b,c) . Moreover, the decrease in S1P was notably sharp at the boundary between the marginal zone and the red pulp (Fig. 2a,c) A r t i c l e s those in the red pulp (Fig. 2a) ; we suspect that this reflected the more elongated shape of macrophages in the marginal zone, which led us to image a sheet of membrane more frequently than a crisp edge.
To assess whether red pulp macrophages were faithful reporters of S1P, we took several approaches. First, we treated S1P reporter mice with the small-molecule drug FTY720, which is phosphorylated in vivo and binds S1PR1 (ref. 7); we found that FTY720 induced internalization of S1PR1-eGFP in F4/80 + macrophages within the red pulp (Fig. 3a,b) . Second, we purified F4/80 + macrophages from the spleen and incubated them with S1P ex vivo; these cells internalized S1PR1-eGFP in response to increasing concentrations of S1P (Fig. 3c) . Third, we were concerned that widespread overexpression of S1PR1 might itself lower concentrations of signaling-available S1P by binding available lipid. However, much more restricted expression of the reporter on a subset of myeloid cells driven by Cre expressed from the promoter of the gene encoding lysozyme M (Lyz2-Cre) revealed the same pattern of S1P distribution as that revealed by widespread reporter expression driven by Mx1-Cre 33 (Fig. 3d,e) . We also quantified reporter expression and found that it was comparable in marginal zone and red pulp (Fig. 3f) . Fourth, we used tamoxifen-inducible Cre expressed from the promoter of the human gene encoding ubiquitin (UBC-CreERT2) to induce expression of the reporter shortly before analysis and observed the same pattern of S1P distribution (Supplementary Fig. 3d ). Finally, we confirmed the pattern in a second cell type. We transduced primary B cells with the S1P reporter and transferred them into wild-type recipients and found that B cells in the marginal zone internalized S1PR1-eGFP more frequently than those in the red pulp did (Fig. 3g,h) .
To determine how the boundary between the marginal zone and red pulp was maintained in the absence of a physical barrier, we considered the possibility that S1P-degrading enzymes in the red pulp rapidly remove S1P entering from the marginal zone. Six S1P-degrading enzymes are known 11 (Supplementary Fig. 3e ). The lipid phosphate phosphatases are of particular interest, as they sit on the plasma membrane with their active sites in the extracellular space, which makes them well positioned to shape S1P gradients. Lipid phosphate phosphatase 3 (LPP3) maintains low concentrations of S1P in the thymus 34 ; here we sought to determine whether LPP3 had any function in the spleen. We bred our S1P reporter mice onto an LPP3-deficient background to generate mice with the S1P reporter, Mx1-Cre and two loxP-flanked alleles encoding LPP3 (Ppap2b f/f ). We treated the mice with poly(I:C) at 3-5 d after birth (to turn the S1P reporter on and elicit excision of Ppap2b by Mx1-Cre) 35 and found that in the absence of LPP3, the abundance of S1P increased in the red pulp (Fig. 4a) . Internalization of S1PR1-eGFP was evident both when we compared broad views of the red pulp (Fig. 4a) and when we specifically compared F4/80 + macrophages in LPP3-sufficient (control) mice with those in LPP3-deficient mice (Fig. 4b) . The increase in S1P was reflected in a lower ratio of eGFP to tRFP on the surface of macrophages in the red pulp of LPP3-deficient mice than on their LPP3-sufficient counterparts (Fig. 4c) . The finding that the abundance of S1P was low in the red pulp might explain the observations that plasma cells and hematopoietic stem cells require S1PR1 to exit the red pulp into the venous sinuses 25, 26 ; these cells might simply be following an S1P gradient out of the organ. The requirement for LPP3 for separation of the marginal zone from the red pulp confirmed the importance of LPP3 in regulating signaling-available S1P in vivo.
Analysis of S1P's distribution in the white pulp
The results obtained with our S1P reporter mouse confirmed that there was little signaling-available S1P deep in the white pulp; CD169 + Supplementary Fig. 3a) . (e) Quantification of S1P reporting in the marginal zone and red pulp of S1P (hCD2 Lyz2-Cre) reporter mice, presented as the ratio of eGFP to tRFP for each tRFP + pixel (marking the surface of reporter-expressing Lyz2-Cre + cells), averaged over a defined area of at least 4 × 10 2 µm 2 (each marginal zone data point) or at least 1 × 10 3 µm 2 (each red pulp data point) (normalized as in Fig. 2b ). (f) Quantification of reporter density in red pulp and marginal zone, presented as tRFP intensity per µm 2 , of the areas analyzed in Figure 2b ; the densities for each mouse were normalized such that the average density for the marginal zone was 1.0 (to account for different microscope settings on different days). npg macrophages and other cell types in this location had little internalized S1PR1-eGFP ( Fig. 5a and Supplementary Figs. 4 and 5 ). In contrast, CD169 + macrophages and other cell types in the white pulp at the border of the marginal sinus were clearly sensing S1P (Fig. 5a and Supplementary Figs. 4 and 5) . The sensing of S1P decayed gradually with distance from the marginal zone in the white pulp (Fig. 5b) .
Although we were unable to determine formally whether cells adjacent to the marginal sinus sensed S1P because S1P had entered the white pulp or because these cells extended processes into the marginal zone, our results demonstrated that cells in the white pulp did sense S1P. That observation was consistent with structural studies that have revealed gaps in the marginal sinus wall, which is formed by anastomosing vessels 36, 37 ; these gaps might facilitate extension of processes into the marginal zone or leakage of S1P into the white pulp. The observation was also consistent with the finding that S1P receptor 2 (which antagonizes the migration of cells toward chemokines) expressed by germinal center B cells and T cells maintains the integrity of germinal center clusters 22, 23 . We found that LPP3 regulated the sensing of S1P in the white pulp as well as the red pulp; S1P was sensed by cells farther from the marginal sinus in LPP3-deficient mice than in LPP3-sufficient mice (Fig. 5c,d ). These findings suggested that S1P was sensed by cells in the white pulp and that LPP3 regulated the range of S1P availability.
Role of LPP3 in MZ B cell shuttling
The finding that LPP3 regulated the distribution of signaling-available S1P in the spleen suggested that the migration of cells of the immune system might be disrupted in LPP3-deficient mice. To test this, we analyzed the effect of LPP3 on the shuttling of MZ B cells. We chose this step because it is early in the immune response and hence is unlikely to Fig. 2c . The data can be fit with the equation y = 0.54 + 0.002 × x (x and y as in Fig. 2c) . A Student's t-test of the hypothesis that the ratio of eGFP to tRFP does not vary with distance (that the true slope of the curve is zero) yielded a P value of <0.0001. (c) Microscopy of sections of spleen from an LPP3-deficient mouse and LPP3-sufficient mouse (presented as in Fig. 2a) . Dashed lines indicate boundaries between marginal zone and white pulp. Scale bars, 20 µm. (d) Quantification of S1P reporting in the white pulp from LPP3-deficient and LPP3-sufficient mice, at various distances (horizontal axis) from the marginal zone-white pulp border, in bands 30 µm thick (calculated as in Fig. 2b ). *P < 0.01 and **P < 0.0001 (two-tailed unpaired Student's t-test). Data are representative of seven experiments with seven mice (a), are from one experiment (pooling of 84 points in five sections from one mouse) representative of three experiments with three mice (b; mean ± s.e.m.), are representative of three experiments with three pairs of mice (c) or are pooled from three experiments with two LPP3-deficient and three LPP3-sufficient mice, with one to five sections per mouse (d; mean ± s.e.m.).
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A r t i c l e s be confounded by effects of LPP3 on multiple cell types, and because the role of S1P gradients in the shuttling of MZ B cells has not been addressed directly. Specifically, we tested the hypothesis that LPP3 is required for MZ B cells to return efficiently from the B cell follicles, where they deposit complement-coated antigen for B cell surveillance, to the marginal zone, where they pick up more cargo from the blood. S1pr1 −/− MZ B cells and MZ B cells in mice treated with FTY720 remain in the follicles, presumably because they cannot follow the S1P gradient back to the marginal zone 38 . We predicted that in the presence of the increased abundance of S1P in the B cell follicles of LPP3-deficient mice, the attraction of the marginal zone would be blunted and MZ B cells would remain longer in the B cell follicles before returning to the marginal zone.
If MZ B cells were retained longer in the B follicles, this would result in a greater fraction of MZ B cells in the follicles than in the marginal zone. By histology, we observed redistribution of MZ B cells from the marginal zone to the follicles in LPP3-deficient mice (Ppap2b f/f Mx1-Cre + mice treated with poly(I:C) 3-5 days after birth) (Fig. 6a) . To quantify the redistribution, we took advantage of a technique for the selective labeling of blood-exposed cells 39 . We gave mice intravenous injection of a phycoerythrin (PE)-conjugated antibody to the leukocyte common antigen CD45, which does not cross endothelial barriers within 5 min. At 5 min after that injection, we quantified the fraction of MZ B cells that were PE + and hence in the marginal zone (Supplementary Fig. 6a ). We found that 40% of MZ B cells were in the marginal zone in LPP3-deficient mice, while 68% were in the marginal zone in their LPP3-sufficient littermates (Fig. 6b,c) . FTY720 served as a positive control for the redistribution of MZ B cells to the follicles (Fig. 6a-c) ; on the basis of the down-modulation of S1PR1 on bulk follicular B cells (data not shown), we expected the effect of FTY720 to be more severe than the loss of LPP3. The total number of MZ B cells did not vary in LPP3-deficient mice versus their LPP3-sufficient littermates (Fig. 6d ).
An increased fraction of MZ B cells in the follicles might reflect retention of MZ B cells in the follicles for too long a time, as we hypothesized. Alternatively, it might reflect retention of MZ B cells in the marginal zone for too brief a time. To investigate whether MZ B cells were retained longer in the follicles of LPP3-deficient mice, we measured their residence time 40 . We analyzed mice in groups of four littermates: two LPP3-deficient mice and two LPP3-sufficient mice. One pair of LPP3-deficient and LPP3-sufficient mice received injection of a control antibody, which gave us a 'time 0' measurement of the number of MZ B cells in the B cell follicles; the other pair of LPP3-deficient and LPP3-sufficient mice received injection of blocking antibodies to integrins α 4 and α L (Supplementary Fig. 6b ). This antibody blockade releases MZ B cells from the marginal zone, and they are carried by flow into circulation; over time, MZ B cells are also lost from the follicles, as they exit into the marginal zone and are carried out of the spleen 40 . At 2.5 h after injection, we quantified MZ B cells in the B cell follicles. We found that in LPP3-deficient mice, 79% of MZ B cells remained in the B cell follicles after integrin blockade, while in their LPP3-sufficient littermates, only 34% remained (Fig. 6e) . This finding indicated that MZ B cells were retained longer in the B cell follicles in LPP3-deficient mice.
We also predicted that MZ B cells themselves in the B cell follicles would have reduced expression of surface S1PR1 in the absence of LPP3, as they would be exposed to higher concentrations of S1P. Although MZ B cells themselves did not detectably express the S1P reporter, and the staining of endogenous S1PR1 on MZ B cells had a very high background (although the S1PR1 stain on MZ B cells from LPP3-deficient mice overlapped the stain on MZ B cells from FTY720-treated LPP3-sufficient mice, we suspect that there was nonetheless more surface S1PR1 remaining on cells in LPP3-deficient mice than on those from FTY720-treated LPP3-sufficient mice), we consistently observed less endogenous S1PR1 on the surface of MZ B cells in the follicles of LPP3-deficient mice than on those of their LPP3-sufficient littermates (Fig. 6f,g ). 
We then sought to determine which cells needed LPP3 to facilitate the shuttling of MZ B cells. We began by making bone marrow chimeras in which either radiation-sensitive hematopoietic cells were LPP3-deficient cells or radiation-resistant cells were LPP3-deficient cells. We found that LPP3 in the two compartments was largely redundant in regulating the positioning of MZ B cells, although there was significant redistribution of MZ B cells to the B cell follicles when LPP3 was lost on radiationsensitive hematopoietic cells (Fig. 7a) . Among the hematopoietic cells that we assayed, F4/80 hi macrophages had abundant expression of LPP3 transcripts (Fig. 7b) . We hypothesized that this high LPP3 expression might be shared by other macrophage subsets (which could not be cleanly purified for quantitative PCR) and that macrophages sitting in or adjacent to the marginal zone might limit the penetration of S1P into the follicle. We deleted LPP3 in macrophages through the use of Cre expressed from the promoter of the gene encoding the receptor for colonystimulating factor (Csf1r-Cre) 41 and found that this resulted in redistribution of MZ B cells to the B cell follicles and a reduction in surface expression of S1PR1 on MZ B cells in the follicles (Fig. 7c,d) . The development of mouse strains expressing Cre recombinases that specifically target splenic macrophage subsets will be invaluable for delineating the mechanism of this. Notably, MZ B cells themselves also expressed detectable amounts of LPP3, and deletion of LPP3 in B cells through the use of Cre expressed from the promoter of the gene encoding immunoglobulin-α subunit of the B cell antigen receptor (Mb1-Cre) 42 also resulted in a small but consistent redistribution of MZ B cells to the B cell follicles (Fig. 7e,f) . We generated mixed-bone marrow chimeras by reconstituting wild-type mice with 10% LPP3-deficient bone marrow and 90% wild-type bone marrow or with 10% bone marrow from the LPP3-sufficient littermates and 90% wild-type bone marrow. Analysis of these chimeras suggested that the role of LPP3 in B cells was not cell intrinsic and instead reflected collective degradation of the lipid; when only 10% of B cells lacked LPP3 and 90% of B cells were wild-type, the LPP3-deficient MZ B cells shuttled normally (Supplementary Fig. 6c ). These findings demonstrated that LPP3 expression by multiple cell types regulated the shuttling of MZ B cells.
DISCUSSION
We have developed a tool for mapping signaling-available S1P in tissues by a strategy that might be widely applicable to other small molecules, lipids and peptides that signal through surface receptors. Here we used this tool to map splenic S1P. As expected, S1P was abundant in the marginal zone and had low abundance deep in the white pulp. Unexpectedly, the concentration of S1P was low in many regions of the blood-rich red pulp, particularly areas dense with F4/80 + macrophages. Moreover, cells in the white pulp adjacent to the marginal sinus sensed substantial S1P. These observations reconcile some of the apparently contradictory roles of S1P in cell trafficking within the spleen. Finally, we found that LPP3 maintained low concentrations of splenic S1P and enabled efficient return of shuttling MZ B cells from the white pulp to the marginal zone.
We expect that the S1P reporter will be a model for the detection of other elusive signaling molecules in vivo. For example, these principles could be used to understand how the distribution of 7α-25 hydroxycholesterol changes upon inflammation, to locate the cytokine TGF-β released from the inhibitory latency-associated protein, to define the shape of lysophosphatidic acid gradients that induce melanoma metastasis, and to determine the range of formyl peptides released from dying cells 43 . Two complementary mouse models for identifying cells that have experienced S1PR1 signaling have been reported; one modifies endogenous S1PR1 through use of the 'Tango' system 44 , and the other replaces endogenous S1PR1 with S1PR1-eGFP 45 . The reporter we presented here differs in that we measured the distribution of S1P itself. Our S1P reporter distinguished ligand-dependent receptor activation from ligand-independent receptor activation, enabled measurement of S1P in areas in which the other four S1P receptors (S1PR2-S1PR5) dominate, and allowed measurement of differential S1P signaling across a cell. Together, the receptor and ligand reporters provide a powerful set of tools with which to delineate the role of extracellular lipid.
Our S1P reporter revealed exquisitely tight regulation of signalingavailable S1P. Surprisingly, the presence of blood cannot be used to npg predict the amount of signaling-available S1P, despite the micromolar concentrations of S1P in plasma, nor can the presence of red blood cells, the primary producers of blood S1P, be used to predict this. Many regions of the red pulp had little signaling-available S1P, although the reticular meshwork of the red pulp has a higher hematocrit than peripheral blood has 46 . The concentration of S1P dropped sharply at the boundary between the marginal zone and the red pulp, although there is no known physical barrier between the two compartments. However, cells in the B cell follicle, in proximity to the marginal sinus, were able to detect S1P. The tight control of S1P gradients might explain how a single lipid can simultaneously direct many cell movements and emphasizes the need for this S1P reporter. LPP3 has an important role in shaping S1P gradients in the spleen and in the thymus and cerebellum as well 34, 47 . We predict that LPP3 regulates the migration of many cell types beyond MZ B cells, and future work should test this hypothesis. It will also be useful to understand the different roles of LPP3 in different subsets of cells, as well as how LPP3 expression and S1P gradients are altered in inflammation. Ultimately, the ability to map the distribution of signaling lipids will offer deep mechanistic insight into how and when these signals regulate immunological function.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Mice. Ppap2b f/f mice 35 , Mx1-Cre mice 1 , Lyz2-Cre mice 33 , UBC-CreERT2 mice 48 , Cd69 −/− mice 49 , Csf1r-Cre mice 41 , Mb1-Cre mice 42 and UBC-GFP mice 50 have been described. CD45.1 + congenic C57BL/6 mice were obtained from the National Cancer Institute. S1P reporter mice were generated in the transgenic facility at the University of California San Diego Moores Cancer Center. Mice were used at 8-20 weeks of age, and female and male mice were used depending on availability (we observed no sex differences in any of the parameters measured). No animals were excluded from analysis unless they were clearly sick (hunched, low body weight). For the induction of Mx1-Cre, 3-to 5-day-old mice received a single intraperitoneal injection of 50-70 µl pI-pC (GE Healthcare) at a concentration of 2 mg/ml in PBS. All mice in each litter (LPP3-deficient mice and controls) were treated identically. For the induction of UBC-CreERT2, adult mice received daily intraperitoneal injections of 200 µg of tamoxifen for 5 d, and mice were analyzed 5 d after the final tamoxifen dose. For bone marrow chimeras, recipients were lethally irradiated by either two doses of 6.6 Gray separated by 3 h or a single dose of 13 Gray from a cesium source, followed by intravenous transfer of 2 × 10 6 to 10 × 10 6 bone marrow cells. Chimeras were analyzed at least 8 weeks after transplantation. Mice were housed in specific pathogen-free conditions at the Skirball Institute Animal Facility. All animal experiments were performed in accordance with protocols approved by the New York University Institutional Animal Care and Use Committee. S1P reporter design. The S1P reporter is as described in Figure 1a . We further tagged S1PR1 NB -tRFP with the hemagglutinin epitope (YPYDVPDYA) and S1PR1-eGFP with FLAG (DYKDDDDK). The tags were placed 17 amino acids from the amino terminus of the receptors, because that terminus is prone to cleavage. A signal sequence (MDSKGSSQKGSRLLLLLVVSNLLLCQGVVSD) preceding S1PR1 NB -tRFP and S1PR1-eGFP was retained from previous constructs that were well expressed. The nucleotide sequences for the two receptors were codon diversified and optimized for mouse. The targeting vector has been described 28 .
Mouse treatments. For intravenous labeling with PE, mice were given an injection in the tail vein of 2 µg PE-anti-CD45.2 (104; BioLegend) and/or 2 µg PE-anti-CD45.1 (A20; BioLegend) in 100 µl PBS, and were euthanized precisely 5 min later. The spleen was quickly harvested and processed through a 70 µm cell strainer in 5 ml ice-cold staining buffer (1 × PBS, 2% FBS, 0.5 mM EDTA and 0.1% sodium azide, pH 7.3).
For integrin blockade, mice were given intravenous injection of 100 µg monoclonal antibody to integrin α 4 (PS/2; BioXCell) and 100 µg monoclonal antibody to integrin α L (M17/4; BioXCell). Rat immunoglobulin G2a antitrinitrophenol (2A3; BioXCell) and rat immunoglobulin G2b antibody to keyhole limpet hemocyanin (LTF-2; BioXCell) served as isotype-matched control antibodies.
Mice were treated with various doses of FTY720 (Cayman Chemical). For MZ B cell-shuttling experiments, mice were treated with FTY720 at a dose of 1 mg per kg body weight (mg/kg) intraperitoneally the night before being killed. For immunofluorescence experiments, mice were treated with either 1 mg/kg intravenously 6 h before being killed, or 3 mg/kg intraperitoneally 18 h before being killed followed by 2 mg/kg intravenously 6 h before being killed.
Confocal microscopy of cultured cells. The coding region of the S1P reporter (S1PR1 NB -TagRFP version) was cloned into the pMXs retroviral vector; Plat-E packaging cells were used to generate retrovirus; and WEHI-231 cells were transduced with viral supernatant. These cells were not recently authenticated or tested for mycoplasma. F4/80 + macrophages were isolated from spleen by mechanical disruption followed by positive selection using an EasySep mouse biotin selection kit according to the manufacturer's instructions (Stemcell Technologies). Borosilicate coverglass chambers (Nunc) were prepared by 2 h of incubation at 37 °C with 1 µg/ml human fibronectin (Corning) in PBS. Cells were plated in the chambers and were incubated for 45 min at 37 °C with the appropriate concentration of S1P (Sigma) or 1 µM PMA (phorbol 12-myristate 13-acetate; Sigma) diluted in RPMI media (HyClone) with 0.5% fatty acid-free BSA (Calbiochem). Following incubation, cells were fixed in 1% PFA (Electron Microscopy Services). Cells were visualized by confocal microscopy (without antibody amplification) with a Zeiss LSM710 inverted confocal microscope with a 63× oil-immersion objective and ZEN 2010 software. Images were processed with ImageJ v1.49.
Confocal microscopy of tissue sections. Mice were lethally anesthetized and fix-perfused with 1% PFA in PBS. Organs were harvested, then were fixed in 4% PFA for 1 h at room temperature (22-25 °C) with gentle shaking, dehydrated overnight in 30% sucrose in 1 × PBS at 16 °C with gentle shaking, embedded in OCT (Sakura), and snap-frozen in dry ice-cold 2-methylbutane. Sections 8-20 µm in thickness were cut, then were fixed with ice cold acetone for 10-15 min and air dried. All staining was performed at room temperature (22-25 °C) . Sections were permeabilized for 10 min with 0.5% Triton X-100 in PBS, then were washed and then incubated for 10-30 min with 0.1% Triton X-100 5% normal goat and 5% normal donkey serum. They were then were washed again and then incubated for 1 h with polyclonal chicken anti-GFP (Abcam, ab13970) and polyclonal rabbit anti-TagRFP (Evrogen, AB234), then were washed again and then incubated with polyclonal Alexa 
Retroviral transduction of primary B cells.
The coding region of sequence encoding the S1P reporter (hCD2-tRFP) was cloned into the pMXs retroviral vector, and Plat-E packaging cells were used for the generation of retrovirus. B cells were purified from lymph nodes and spleen by cell sorting (gated as B220 + CD23 hi CD1d lo ) or magnetic bead separation (positive selection for CD19 using an EasySep biotin selection kit; StemCell Technologies). The purified B cells were activated overnight with 25 µg/ml LPS (Sigma), then were transduced with a retrovirus encoding the S1P reporter by 'spinfection' (1,258g, 90 min, 32 °C), incubated overnight with 25 µg/ml LPS, transduced once more with the retrovirus, and allowed to 'rest' overnight without LPS, then were transferred intravenously into wild-type recipients (the transferred transduced cells were >94% B220 + ). The following morning, recipient mice were killed and their spleens were analyzed by confocal microscopy.
Flow cytometry. Lymphocytes were isolated by mechanical disruption and filtration through a 70-µm cell strainer and were enumerated with a cell counter (Beckman Coulter) set to detect nuclei between 3.5 and 7.5 µm. Splenic stromal cells were isolated as described 34 . Cells were stained and analyzed on an LSRII (BD) or sorted on a MoFlo (Beckman Coulter) or FACSAria (BD). Data were analyzed with FlowJo software v. 8.7 and v. 10.0.8 (TreeStar).
Quantitative RT-PCR. For quantification of the abundance of messenger RNA in cells, total RNA was extracted from sorted cell populations with TRIZOL according to the manufacturer's instructions (Invitrogen). Before reverse transcription, RNA was treated with DNase I (Invitrogen). The RNA was converted to cDNA with a Superscript III Firstrand Synthesis System according to the manufacturer's instructions (Invitrogen) with a mixture of oligo(dT) and
